Cara Therapeutics reports that its Head of Clinical Development, Paul Tiseo, Ph.D., will present a poster at the American Society of Health-System Pharmacists 2015 Midyear Clinical Meeting, to be held December 6-10 in New Orleans, Louisiana.

Cara is focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors.